HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC labeling rule

This article was originally published in The Rose Sheet

Executive Summary

FDA "feedback" meeting with the Cosmetic, Toiletry and Fragrance Association and Consumer Healthcare Products Association is scheduled for June 29 at 10 a.m. The meeting will be held at 5600 Fishers Lane, Conference Room D in Rockville, Md. CHPA said it wanted to hold discussions with the agency on the final rule before conducting a member survey evaluating the effect of the new regulation ("The Rose Sheet" June 7, p. 4). Discussion is expected to address the use of dual-columns as requested by CHPA; in a May 27 letter, OTC Office then-Acting Director Debra Bowen, MD, said the agency would be "willing to consider" the alternative format
UsernamePublicRestriction

Register

RS006822

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel